Yiheng Tu1, Jiliang Fang2, Jin Cao3, Zengjian Wang1, Joel Park1, Kristen Jorgenson1, Courtney Lang1, Jun Liu2, Guolei Zhang2, Yanping Zhao2, Bing Zhu4, Peijing Rong5, Jian Kong6. 1. Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA. 2. Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. 3. Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA; School of Acupuncture Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China. 4. Institution of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China. 5. Institution of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: drrongpj@163.com. 6. Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA. Electronic address: kongj@nmr.mgh.harvard.edu.
Abstract
BACKGROUND: Major depression is the fourth leading cause of disability worldwide and poses a socioeconomic burden worldwide. Transcutaneous vagus nerve stimulation (tVNS) is a promising noninvasive clinical device that may reduce the severity of major depression. However, the neural mechanism underlying continuous tVNS has not yet been elucidated. OBJECTIVE: We aimed to explore the effect of hypothalamic subregion functional connectivity (FC) changes during continuous tVNS treatment on major depressive disorder (MDD) patients and to identify the potential biomarkers for treatment outcomes. METHODS: Forty-one mild to moderate MDD patients were recruited and received either real or sham tVNS treatment for 4 weeks. We used a seed-to-whole brain approach to estimate the FC changes of hypothalamic subregions and their surrounding control areas during continuous tVNS treatment and explored their association with clinical outcome changes after 4 weeks of treatment. RESULTS: Of the thirty-six patients that completed the study, those in the tVNS group had significantly lower scores on the 24-item Hamilton Depression (HAM-D) Rating Scale compared to the sham tVNS group after 4 weeks of treatment. The FC between the bilateral medial hypothalamus (MH) and rostral anterior cingulate cortex (rACC) was significantly decreased during tVNS but not during sham tVNS. The strength of this FC was significantly correlated with HAM-D improvements after 4 weeks of tVNS. CONCLUSION: The FC between the bilateral MH and rACC may serve as a potential biomarker for the tVNS state and predict treatment responses. Our results provide insights into the neural modulation mechanisms of continuous tVNS and reveal a potential therapeutic target for MDD patients.
BACKGROUND:Major depression is the fourth leading cause of disability worldwide and poses a socioeconomic burden worldwide. Transcutaneous vagus nerve stimulation (tVNS) is a promising noninvasive clinical device that may reduce the severity of major depression. However, the neural mechanism underlying continuous tVNS has not yet been elucidated. OBJECTIVE: We aimed to explore the effect of hypothalamic subregion functional connectivity (FC) changes during continuous tVNS treatment on major depressive disorder (MDD) patients and to identify the potential biomarkers for treatment outcomes. METHODS: Forty-one mild to moderate MDDpatients were recruited and received either real or sham tVNS treatment for 4 weeks. We used a seed-to-whole brain approach to estimate the FC changes of hypothalamic subregions and their surrounding control areas during continuous tVNS treatment and explored their association with clinical outcome changes after 4 weeks of treatment. RESULTS: Of the thirty-six patients that completed the study, those in the tVNS group had significantly lower scores on the 24-item Hamilton Depression (HAM-D) Rating Scale compared to the sham tVNS group after 4 weeks of treatment. The FC between the bilateral medial hypothalamus (MH) and rostral anterior cingulate cortex (rACC) was significantly decreased during tVNS but not during sham tVNS. The strength of this FC was significantly correlated with HAM-D improvements after 4 weeks of tVNS. CONCLUSION: The FC between the bilateral MH and rACC may serve as a potential biomarker for the tVNS state and predict treatment responses. Our results provide insights into the neural modulation mechanisms of continuous tVNS and reveal a potential therapeutic target for MDDpatients.
Authors: Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava Journal: Am J Psychiatry Date: 2006-01 Impact factor: 18.112
Authors: Michael Von Korff; Paul Crane; Michael Lane; Diana L Miglioretti; Greg Simon; Kathleen Saunders; Paul Stang; Nancy Brandenburg; Ronald Kessler Journal: Pain Date: 2005-02 Impact factor: 6.961
Authors: D A Seminowicz; H S Mayberg; A R McIntosh; K Goldapple; S Kennedy; Z Segal; S Rafi-Tari Journal: Neuroimage Date: 2004-05 Impact factor: 6.556
Authors: T E Schlaepfer; C Frick; A Zobel; W Maier; I Heuser; M Bajbouj; V O'Keane; C Corcoran; R Adolfsson; M Trimble; H Rau; H-J Hoff; F Padberg; F Müller-Siecheneder; K Audenaert; D Van den Abbeele; K Matthews; D Christmas; Z Stanga; M Hasdemir Journal: Psychol Med Date: 2008-01-04 Impact factor: 7.723
Authors: Adam D Farmer; Adam Strzelczyk; Alessandra Finisguerra; Alexander V Gourine; Alireza Gharabaghi; Alkomiet Hasan; Andreas M Burger; Andrés M Jaramillo; Ann Mertens; Arshad Majid; Bart Verkuil; Bashar W Badran; Carlos Ventura-Bort; Charly Gaul; Christian Beste; Christopher M Warren; Daniel S Quintana; Dorothea Hämmerer; Elena Freri; Eleni Frangos; Eleonora Tobaldini; Eugenijus Kaniusas; Felix Rosenow; Fioravante Capone; Fivos Panetsos; Gareth L Ackland; Gaurav Kaithwas; Georgia H O'Leary; Hannah Genheimer; Heidi I L Jacobs; Ilse Van Diest; Jean Schoenen; Jessica Redgrave; Jiliang Fang; Jim Deuchars; Jozsef C Széles; Julian F Thayer; Kaushik More; Kristl Vonck; Laura Steenbergen; Lauro C Vianna; Lisa M McTeague; Mareike Ludwig; Maria G Veldhuizen; Marijke De Couck; Marina Casazza; Marius Keute; Marom Bikson; Marta Andreatta; Martina D'Agostini; Mathias Weymar; Matthew Betts; Matthias Prigge; Michael Kaess; Michael Roden; Michelle Thai; Nathaniel M Schuster; Nicola Montano; Niels Hansen; Nils B Kroemer; Peijing Rong; Rico Fischer; Robert H Howland; Roberta Sclocco; Roberta Sellaro; Ronald G Garcia; Sebastian Bauer; Sofiya Gancheva; Stavros Stavrakis; Stefan Kampusch; Susan A Deuchars; Sven Wehner; Sylvain Laborde; Taras Usichenko; Thomas Polak; Tino Zaehle; Uirassu Borges; Vanessa Teckentrup; Vera K Jandackova; Vitaly Napadow; Julian Koenig Journal: Front Hum Neurosci Date: 2021-03-23 Impact factor: 3.169
Authors: Ronald G Garcia; Justine E Cohen; Arielle D Stanford; Aileen Gabriel; Jessica Stowell; Harlyn Aizley; Riccardo Barbieri; David Gitlin; Vitaly Napadow; Jill M Goldstein Journal: J Psychiatr Res Date: 2021-08-02 Impact factor: 5.250
Authors: Monja P Neuser; Vanessa Teckentrup; Anne Kühnel; Manfred Hallschmid; Martin Walter; Nils B Kroemer Journal: Nat Commun Date: 2020-07-16 Impact factor: 14.919